Ceftriaxone

Sold as Litha ceftriaxone, Aspen ceftriaxone, Oframax, Fraxone, Triaphin, Sabax-ceftriaxone, Rociject, Rezone, Adco ceftriaxone, Ceftriaxone pharma-q, Rocitrax, Ciplacef, Cipla-ceftriaxone, Traxiject, Ceftriaxone-hexal, Uniceft, Fresenius ceftriaxone, Merck-ceftriaxone, Gulf ceftriaxone, Cephtrifect, Seftry, Naroxine, Ceftriaxone iv ipharma, Ceftriaxone im ipharma, Nectram, Ceftriaxone propan, Ceftriaxone resmed, Triaxiphin, Kocef, Ceftriaxone-combinopharm, Ceftriaxone safeline, Ceftriaxone austell, Apex-ceftriaxone, Medaxone, Rocephin

C₁₈H₁₈N₈O₇S₃554.60 g/mol

(6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 5479530.

Loading Wikipedia summary

Registration

Applicants: 23
Registrations: 91
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Litha pharmaCancelled	Litha ceftriaxone, Aspen ceftriaxone	0,5 g, 1 g, 2 g	340043, 340044, 340045, 340046	S4	None
Unimed Healthcare (Pty) Ltd	Oframax, Uniceft	1 g, 250, 500 mg	340318, 340319, 370603, 370604	S4	None
Innovata pharmaceuticalsCertificate held by Innovata Pharmaceuticals Pty (Ltd)	Fraxone	1 g, 250	340320, 340321	S4	PI PIL
Dezzo Trading 392 (Pty) Ltd	Triaphin, Kocef	1 g, 250, 500, 1000	340322, 340323, A380553, A380554, A380555	S4	PI PIL
Adcock Ingram Critical Care (Pty) Ltd4 of 15 cancelled	Sabax-ceftriaxone, Adco ceftriaxone, Nectram, Ceftriaxone propan	1 g, 2 g, 250 mg, 500 mg	350303, 350304, 350305, 350306, 370042, 370043, 370044, 520783, 520784, 520785, 520786, 520787, 520788, 520789, 520790	S4	None
Acino Pharma (Pty) Ltd	Rociject	0,5 g, 1,0 G, 2,0 g	350345, 370352, 370368	S4	None
Resmed healthcare	Rezone, Ceftriaxone resmed	250, 500, 1000 mg, 2000	370001, 530171, A380582, A380583, A390179	S4	PI PIL
Pharma-q Holdings (Pty) Ltd	Ceftriaxone pharma-q	250, 500, 1000	370046, 370048, 370049	S4	None
Brimpharm SA (Pty) Ltd3 of 4 cancelled	Rocitrax, Traxiject	0,5 g, 1,0 g, 2,0 g	370166, 370419, 370420, 370421	S4	None
Cipla Medpro (Pty) LtdCancelled	Ciplacef, Cipla-ceftriaxone	250, 500, 1000	370283, 370284, 370285, 370286, 370287, 370288	S4	None
Sandoz South Africa (Pty) Ltd	Ceftriaxone-hexal	1 g, 2 g	370499, 370500	S4	None
Fresenius Kabi South Africa (Pty) LtdCancelled	Fresenius ceftriaxone	1,0 g, 2 g, 250 mg	380075, 380076, 380078	S4	None
Merck Generics Rsa (Pty) Ltd	Merck-ceftriaxone	1 G/3,5 ML, 1 G/10 ML, 500 mg/2 ML, 500 mg/5 ML	380277, 380333, 380336, 380337	S4	None
Gulf Drug Company (Pty) Ltd	Gulf ceftriaxone, Naroxine	1 g	410524, 441030	S4	None
Ipharma (Pty) Ltd4 of 7 cancelled	Cephtrifect, Ceftriaxone iv ipharma, Ceftriaxone im ipharma	500, 1000, 2000	410866, 410867, 410868, 500656, 500657, 500673, 500674	S4	None
Oethmaan Biosims (Pty) Ltd	Seftry	0,5, 1,0, 2,0	410869, 410870, 410871	S4	None
Ranbaxy (SA) (Pty) Ltd	Triaxiphin	1 g, 250 mg, 500 mg	A380550, A380551, A380552	S4	None
Pharmaplan (Pty) Ltd	Ceftriaxone-combinopharm	1,0 g, 2,0 g, 250 mg, 500 mg	A380608, A380609, A380610, A380611	S4	None
Safeline Pharmaceuticals (Pty) LtdCancelled	Ceftriaxone safeline	1 G -, 250 mg -, 500 mg -	A390055, A390056, A390057	S4	None
Austell Pharmaceuticals (Pty) Ltd	Ceftriaxone austell	1 g	A390176	S4	None
Camox Pharmaceuticals (Pty) LtdCancelled	Apex-ceftriaxone	1 g	A390303	S4	None
Cospharm Investments (Pty) Ltd	Medaxone	1 g, 250 mg, 500 mg	A400198, A400199, A400200	S4	None
Roche Products (Pty) Ltd2 of 4 cancelled	Rocephin	1 g, 2 g, 250 mg, 500 mg	R0044, R0045, R0046, R0047	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Litha ceftriaxone 0,5 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	0,5 gInjection	34004334/20.1.1/0043	Cancelled	S4	None
Aspen ceftriaxone 1 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 gInjection	34004434/20.1.1/0044	Cancelled	S4	None
Litha ceftriaxone 2 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2 gInjection	34004534/20.1.1/0045	Cancelled	S4	None
Litha ceftriaxone 2 g infusion EACH BOTTLE CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2 gInfusion	34004634/20.1.1/0046	Cancelled	S4	None
Oframax 250 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250	34031834/20.1.1/0318	Registered	S4	None
Oframax 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	34031934/20.1.1/0319	Registered	S4	None
Fraxone 250 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250Powder for injection,	34032034/20.1.1/0320Approved 1 October 2024	Registered	S4	PI PIL
Fraxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	34032134/20.1.1/0321	Registered	S4	None
Triaphin 250 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250Powder for solution for injection.	34032234/20.1.1/0322Approved 12 April 2023	Registered	S4	PI PIL
Triaphin 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	34032334/20.1.1/0323	Registered	S4	None
Sabax-ceftriaxone 250 MG EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	35030335/20.1.1/0303	Registered	S4	None
Sabax-ceftriaxone 500 MG EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	35030435/20.1.1/0304	Registered	S4	None
Sabax-ceftriaxone 1 g EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	35030535/20.1.1/0305	Registered	S4	None
Sabax-ceftriaxone 2 g EACH VIAL CONTAINS:CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2 g	35030635/20.1.1/0306	Registered	S4	None
Rociject 1,0 g injection EACH VIAL CONTAINS: CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1,0 GInjection	35034535/20.1.1/0345	Registered	S4	None
Rezone 1000 injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1000Injection	37000137/20.1.1/0001	Registered	S4	None
Adco ceftriaxone 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	37004237/20.1.1/0042	Registered	S4	None
Adco ceftriaxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	37004337/20.1.1/0043	Registered	S4	None
Adco ceftriaxone 2 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2 g	37004437/20.1.1/0044	Registered	S4	None
Ceftriaxone 250 pharma-q EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250	37004637/20.1.1/0046	Registered	S4	None
Ceftriaxone 500 pharma-q EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500	37004837/20.1.1/0048	Registered	S4	None
Ceftriaxone 1000 pharma-q EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000	37004937/20.1.1/0049	Registered	S4	None
Rocitrax 1,0 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1,0 gInjection	37016637/20.1.1/0166	Cancelled	S4	None
Ciplacef 250 EACH 5,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250	37028337/20.1.1/0283	Cancelled	S4	None
Ciplacef 500 EACH 5,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500	37028437/20.1.1/0284	Cancelled	S4	None
Ciplacef 1000 EACH 10,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000	37028537/20.1.1/0285	Cancelled	S4	None
Cipla-ceftriaxone 250 EACH 5,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250	37028637/20.1.1/0286	Cancelled	S4	None
Cipla-ceftriaxone 500 EACH 5,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500	37028737/20.1.1/0287	Cancelled	S4	None
Cipla-ceftriaxone 1000 EACH 10,0 ml SOLUTION CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000	37028837/20.1.1/0288	Cancelled	S4	None
Rociject 2,0 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2,0 gInjection	37035237/20.1.1/0352	Registered	S4	None
Rociject 0,5 g injection EACH VIAL CONTAINS :CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 0,5 g	0,5 gInjection	37036837/20.1.1/0368	Registered	S4	None
Traxiject 2,0 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2,0 gInjection	37041937/20.1.1/0419	Cancelled	S4	None
Rocitrax 0,5 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 0,5 g CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 0,5 g	0,5 gInjection	37042037/20.1.1/0420	Cancelled	S4	None
Rocitrax 2,0 g injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2,0 gInjection	37042137/20.1.1/0421	Registered	S4	None
Ceftriaxone-hexal 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	37049937/20.1.1/0499	Registered	S4	None
Ceftriaxone-hexal 2 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2 g	37050037/20.1.1/0500	Registered	S4	None
Uniceft 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	37060337/20.1.1/0603	Registered	S4	None
Uniceft 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	37060437/20.1.1/0604	Registered	S4	None
Fresenius ceftriaxone 2 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2000,0 mg	2 g	38007538/20.1.1/0075	Cancelled	S4	None
Fresenius ceftriaxone 1,0 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1,0 g	38007638/20.1.1/0076	Cancelled	S4	None
Fresenius ceftriaxone 250 MG EACH 10,0 ml VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	38007838/20.1.1/0078	Cancelled	S4	None
Merck-ceftriaxone 500 mg/2 ML EACH 2,0 ml VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg/2 ML	38027738/20.1.1/0277	Registered	S4	None
Merck-ceftriaxone 1 g/3,5 ML EACH 3,5 ml VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1 G/3,5 ML	38033338/20.1.1/0333	Registered	S4	None
Merck-ceftriaxone 1 g/10 ML EACH 10,0 ml VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1 G/10 ML	38033638/20.1.1/0336	Registered	S4	None
Merck-ceftriaxone 500 mg/5 ML EACH 5,0 ml VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg/5 ML	38033738/20.1.1/0337	Registered	S4	None
Gulf ceftriaxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	41052441/20.1.1/0524	Registered	S4	None
Cephtrifect 500 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 0,5 g	500	41086641/20.1.1/0866	Registered	S4	None
Cephtrifect 1000 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1000	41086741/20.1.1/0867	Registered	S4	None
Cephtrifect 2000 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2000	41086841/20.1.1/0868	Registered	S4	None
Seftry 0,5 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 0,5 g	0,5	41086941/20.1.1/0869	Registered	S4	None
Seftry 1,0 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1,0	41087041/20.1.1/0870	Registered	S4	None
Seftry 2,0 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2,0	41087141/20.1.1/0871	Registered	S4	None
Naroxine 1 g EACH VIAL CONTAINS: CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	44103044/20.1.1/1030	Registered	S4	None
Ceftriaxone 500 iv ipharma EACH VIAL CONTAINS: CEFTRIAXONE DISODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500	50065650/20.1.1/0656	Cancelled	S4	None
Ceftriaxone 1000 iv ipharma EACH VIAL CONTAINS: CEFTRIAXONE DISODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000	50065750/20.1.1/0657	Cancelled	S4	None
Ceftriaxone 500 im ipharma EACH VIAL CONTAINS: CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500	50067350/20.1.1/0673	Cancelled	S4	None
Ceftriaxone 1000 im ipharma EACH VIAL CONTAINS: CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000	50067450/20.1.1/0674	Cancelled	S4	None
Nectram 250 MG Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 250 mg	250 mg	52078352/20.1.1/0783	Registered	S4	None
Nectram 500 MG Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 500 mg	500 mg	52078452/20.1.1/0784	Registered	S4	None
Nectram 1 g Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 1,0 mg	1 g	52078552/20.1.1/0785	Registered	S4	None
Nectram 2 g Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 2 g	2 g	52078652/20.1.1/0786	Registered	S4	None
Ceftriaxone 250 MG propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 250 mg	250 mg	52078752/20.1.1/0787	Cancelled	S4	None
Ceftriaxone 500 MG propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 500 mg	500 mg	52078852/20.1.1/0788	Cancelled	S4	None
Ceftriaxone 1 g propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 1 g	1 g	52078952/20.1.1/0789	Cancelled	S4	None
Ceftriaxone 2 g propan Each Vial contains: Ceftriaxone sodium equivalent to ceftriaxone 2 g	2 g	52079052/20.1.1/0790	Cancelled	S4	None
Ceftriaxone 1 000 injection resmed EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1 000,0 mg	1000 mgInjection	53017153/20.1.1/0171Approved 3 August 2022	Registered	S4	PI PIL
Triaxiphin 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1 g	A380550A38/20.1.1/0550	Registered	S4	None
Triaxiphin 250 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	A380551A38/20.1.1/0551	Registered	S4	None
Triaxiphin 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	A380552A38/20.1.1/0552	Registered	S4	None
Kocef-250 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250Injection	A380553A38/20.1.1/0553Approved 22 March 2023	Registered	S4	PI PIL
Kocef-500 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500Injection	A380554A38/20.1.1/0554Approved 22 March 2023	Registered	S4	PI PIL
Kocef-1000 EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1000Injection	A380555A38/20.1.1/0555Approved 22 March 2023	Registered	S4	PI PIL
Rezone 250 injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250Injection	A380582A38/20.1.1/0582	Registered	S4	None
Rezone 500 injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500Injection	A380583A38/20.1.1/0583	Registered	S4	None
Ceftriaxone-combinopharm 1,0 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1,0 g	A380608A38/20.1.1/0608	Registered	S4	None
Ceftriaxone-combinopharm 2,0 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2,0 g	2,0 g	A380609A38/20.1.1/0609	Registered	S4	None
Ceftriaxone-combinopharm 250 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	A380610A38/20.1.1/0610	Registered	S4	None
Ceftriaxone-combinopharm 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	A380611A38/20.1.1/0611	Registered	S4	None
Ceftriaxone - safeline 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 G -	A390055A39/20.1.1/0055	Cancelled	S4	None
Ceftriaxone - safeline 250 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM E EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg -	A390056A39/20.1.1/0056	Cancelled	S4	None
Ceftriaxone - safeline 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM E EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg -	A390057A39/20.1.1/0057	Cancelled	S4	None
Ceftriaxone 1 g austell EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	A390176A39/20.1.1/0176	Registered	S4	None
Rezone 2000 injection EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 2000,0 mg	2000Injection	A390179A39/20.1.1/0179	Registered	S4	None
Apex-ceftriaxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1,0 g	1 g	A390303A39/20.1.1/0303	Cancelled	S4	None
Medaxone 1 g EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 1000,0 mg	1 g	A400198A40/20.1.1/0198	Registered	S4	None
Medaxone 250 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	A400199A40/20.1.1/0199	Registered	S4	None
Medaxone 500 MG EACH VIAL CONTAINS CEFTRIAXONE SODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	A400200A40/20.1.1/0200	Registered	S4	None
Rocephin 250 MG EACH VIAL CONTAINS CEFTRIAXONE DISODIUM EQUIVALENT TO CEFTRIAXONE 250,0 mg	250 mg	R0044R/20.1.1/44	Cancelled	S4	None
Rocephin 500 MG EACH VIAL CONTAINS CEFTRIAXONE DISODIUM EQUIVALENT TO CEFTRIAXONE 500,0 mg	500 mg	R0045R/20.1.1/45	Cancelled	S4	None
Rocephin 1 g EACH VIAL CONTAINS CEFTRIAXONE 1,0 g	1 g	R0046R/20.1.1/46	Registered	S4	None
Rocephin 2 g EACH VIAL CONTAINS CEFTRIAXONE 2,0 g	2 g	R0047R/20.1.1/47	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Ceftriaxone sodium equivalent to ceftriaxone

S4: Ceftriaxone
Consolidated Schedules 06 July 2026, line 5757

Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsFraxone 250, Innovata pharmaceuticals Patient information leaflet (PIL)For patients and carersFraxone 250, Innovata pharmaceuticals

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background